NSW Hepatitis B In Primary Care

In 2021, an estimated 200, 385 people were living with chronic hepatitis B (CHB) in Australia, with 27.5% undiagnosed and 74% were not engaged in regular care (Viral Hepatitis Mapping Project: Hepatitis B, National Report 2021). Guideline-based management and treatment of CHB can prevent liver cancer, with CHB being the primary cause of liver cancer worldwide. Primary care practitioners play a critical role in the diagnosis and management of CHB in the community, and in reducing preventable deaths from liver cancer. Presented by Dr Nada Andric, Hepatitis B s100 community prescriber GP, this webinar will provide participants with crucial knowledge and understanding of hepatitis B and the impact of COVID-19 on patients living with hepatitis B.

Learning Outcomes:

After this webinar, participants will be able to:

•Identify priority populations for hepatitis B testing in Australia

•Interpret hepatitis B serology results.

•Describe the role of primary care in the testing, diagnosis and management of patients with hepatitis B in the community.

Date: Tuesday 31 October 2023

Time: 6:30pm – 8:00pm (AEDT)

Target Audience

General Practitioners, Nurses & other primary healthcare workers based in NSW

Endorsement and CPD

HBV s100 Prescribers will be allocated 1 HBV CPD point.

This is an RACGP-approved CPD activity under the RACGP CPD Program. 1.5 Educational Activity hours.

Funding

This activity is funded by NSW Health. This course is free to attend for professions aligned with the target audience who practice in NSW

Further Information:

For more information please contact Curtis Micallef, click here to send an email.